3 Reasons ABBV is Risky and 1 Stock to Buy Instead
AbbVie trades at $205.51 per share and has stayed right on track with the overall market, gaining 5.2% over the last six months. At the same time, the S&P 500 has returned 5.1%.
3 Reasons to Avoid SNDR and 1 Stock to Buy Instead
Schneider has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $26.09. The stock also fell short of the S&P 500’s 5.1% gain during that period.
Unpacking Q4 Earnings: Xylem (NYSE:XYL) In The Context Of Other Water Infrastructure Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how water infrastructure stocks fared in Q4, starting with Xylem (NYSE:XYL).
3 Reasons to Sell CAL and 1 Stock to Buy Instead
Shareholders of Caleres would probably like to forget the past six months even happened. The stock dropped 59.8% and now trades at $16.98. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid GPK and 1 Stock to Buy Instead
Over the last six months, Graphic Packaging Holding’s shares have sunk to $26.27, producing a disappointing 10.5% loss - a stark contrast to the S&P 500’s 5.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
A Look Back at Video Conferencing Stocks’ Q4 Earnings: 8x8 (NASDAQ:EGHT) Vs The Rest Of The Pack
Let’s dig into the relative performance of 8x8 (NASDAQ:EGHT) and its peers as we unravel the now-completed Q4 video conferencing earnings season.
Spotting Winners: ESAB (NYSE:ESAB) And Professional Tools and Equipment Stocks In Q4
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ESAB (NYSE:ESAB) and the rest of the professional tools and equipment stocks fared in Q4.
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified stocks, starting with Stryker (NYSE:SYK).
Q4 Earnings Recap: Johnson Controls (NYSE:JCI) Tops Commercial Building Products Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the commercial building products industry, including Johnson Controls (NYSE:JCI) and its peers.
Gig Economy Stocks Q4 In Review: Fiverr (NYSE:FVRR) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Fiverr (NYSE:FVRR) and the rest of the gig economy stocks fared in Q4.
Popular Post
- Steadfast US Consumer, Job Market Allay Concerns About Economy Aug 15, 2024
- Netflix stock secures record close as company touts ad sales ahead of NFL, WWE debuts Aug 20, 2024
- Nexstar Media (NASDAQ:NXST) Beats Q4 Sales Targets Feb 27, 2025
- Why Costa Rica Is Taking a Hands-Off Approach to Regulating Crypto Nov 28, 2024
- How To Earn $500 A Month From Designer Brands Stock Ahead Of Q3 Earnings Dec 08, 2024
- Covenant Logistics (CVLG) Stock Trades Down, Here Is Why Jan 24, 2025
- U.S. home prices forecast to rise modestly as Fed cuts rates - Reuters poll Aug 30, 2024
- Blue Bird’s (NASDAQ:BLBD) Q4 Sales Beat Estimates Feb 05, 2025
- Emerging Markets Waver as Traders Weigh Tariffs, US-Ukraine Feud Mar 03, 2025
- Bitcoin Spot ETFs See Fifth Day of Net Inflows Aug 23, 2024